rizatriptan Granules 5 mg, 10 mg

This CDMO specializes in developing and manufacturing solid oral dosage forms, including effervescent tablets, granules, sublingual tablets, orally disintegrating tablets, and soluble granules. They offer comprehensive services from drug product development to commercial manufacturing, as well as proprietary product development and licensing opportunities. Their expertise spans multiple therapy areas, including menopause syndrome, eye health, memory enhancement, cognitive function, metabolic syndrome, PCOS syndrome, and immune system support. The company holds GMP certifications from the EU, Italian Health Authorities, FDA, TGA, and UAE regulatory bodies. They also possess several patents for their innovative technologies and formulations.